Lasa Supergenerics share news, announcements and annual reports
NSE: LASABSE: 540702Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 26 Oct 2026. Previous close ₹4.91.
26 Oct: open ₹4.86, high ₹4.86, low ₹4.67
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹23 Cr3,595th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.47
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −24.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −24.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 42,091
Lasa Supergenerics share news and announcements
825 announcements, routine notices left out, newest first. Page 9 of 17.
Jul 2021
23 Jul · Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
20 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....13 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2021
28 Jun · Compliance Under Regulation 23(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations. 2015.
28 Jun · Results
Details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....28 Jun · Announcement under Regulation 30 (LODR)-Meeting Updates
23 Jun · Legal
Exchange has sought clarification from Lasa Supergenerics Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.23 Jun · Legal
Clarification - Financial Results13 Jun · Proceedings Of The Hon'Ble NCLT / Court Convened Meeting (CCM) Of Equity Shareholders
1 Jun · Analysts
May 2021
31 May · Results
31 May · Board meeting
18 May · Board meeting
Meeting on 31 May 2021: audited results11 May · Equity Shareholders Of Lasa Supergenerics Limited To Be Convened As Per The Directions Of The National Company Law Tribunal, Mumbai Bench On Saturday June 12, 2021 At 10:30 A.M.
Apr 2021
26 Apr · HALF YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER REG 40(9) OF SEBI (LODR) REGULATIONS 2015.
21 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....19 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations,2015 For Period March 31, 2021
14 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 013 Apr · Annual Disclosure
Feb 2021
15 Feb · Analysts
3 Feb · Analysts
1 Feb · Results
1 Feb · Board meeting
1 Feb · Board meeting
1 Feb · Board meeting
Jan 2021
25 Jan · Board meeting
20 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....